About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA recently submitted comments to the NIH Office of Science Policy’s Request for Information on its Draft Intramural Research Program Policy: Promoting Equity Through Access Planning. PhRMA believes that federal investment in science and technology and attracting private sector investment to translate early research discoveries into innovative products is critically important for Americans and patients around the globe.
PhRMA Submits Comments in Response to the NIH Office of Science Policy’s Request for Information on Draft NIH Intramural Research Program Policy image
Comment
Access to Medicines
PhRMA Submits Comments in Response to the NIH Office of Science Policy’s Request for Information on Draft NIH Intramural Research Program Policy
PhRMA Submits Comments in Response to the NIH Office of Science Policy’s Request for Information on Draft NIH Intramural Research Program Policy image